HTG Molecular Diagnostics, Inc.

OTCPK:HTGM.Q Stock Report

Market Cap: US$221.0

HTG Molecular Diagnostics Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

John Lubniewski

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure6.9yrs
CEO ownershipn/a
Management average tenure8.9yrs
Board average tenure5.9yrs

Recent management updates

Recent updates

HTG Molecular Q2 GAAP loss per share widens, revenue down

Aug 11

HTG Molecular Diagnostics amends senior loan facility

Jul 18

Is HTG Molecular Diagnostics (NASDAQ:HTGM) Using Debt In A Risky Way?

Dec 10
Is HTG Molecular Diagnostics (NASDAQ:HTGM) Using Debt In A Risky Way?

Is HTG Molecular Diagnostics (NASDAQ:HTGM) Weighed On By Its Debt Load?

Aug 27
Is HTG Molecular Diagnostics (NASDAQ:HTGM) Weighed On By Its Debt Load?

HTG Molecular completes product design lock for planned transcriptome panel

Jun 14

These Analysts Think HTG Molecular Diagnostics, Inc.'s (NASDAQ:HTGM) Sales Are Under Threat

Mar 26
These Analysts Think HTG Molecular Diagnostics, Inc.'s (NASDAQ:HTGM) Sales Are Under Threat

What Type Of Returns Would HTG Molecular Diagnostics'(NASDAQ:HTGM) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

Jan 20
What Type Of Returns Would HTG Molecular Diagnostics'(NASDAQ:HTGM) Shareholders Have Earned If They Purchased Their SharesThree Years Ago?

HTG shares surge after upbeat 2020 revenue forecast

Jan 05

HTG Molecular Diagnostics announced 1:15 reverse stock split

Nov 23

HTG Molecular Diagnostics (HTGM) Investor Presentation - Slideshow

Nov 18

CEO Compensation Analysis

How has John Lubniewski's remuneration changed compared to HTG Molecular Diagnostics's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2023n/an/a

-US$20m

Dec 31 2022US$914kUS$538k

-US$22m

Sep 30 2022n/an/a

-US$22m

Jun 30 2022n/an/a

-US$22m

Mar 31 2022n/an/a

-US$19m

Dec 31 2021US$737kUS$460k

-US$17m

Sep 30 2021n/an/a

-US$16m

Jun 30 2021n/an/a

-US$17m

Mar 31 2021n/an/a

-US$20m

Dec 31 2020US$1mUS$416k

-US$21m

Sep 30 2020n/an/a

-US$21m

Jun 30 2020n/an/a

-US$20m

Mar 31 2020n/an/a

-US$19m

Dec 31 2019US$1mUS$384k

-US$19m

Sep 30 2019n/an/a

-US$17m

Jun 30 2019n/an/a

-US$17m

Mar 31 2019n/an/a

-US$16m

Dec 31 2018US$1mUS$327k

-US$16m

Compensation vs Market: Insufficient data to establish whether John's total compensation is reasonable compared to companies of similar size in the US market.

Compensation vs Earnings: Insufficient data to compare John's compensation with company performance.

CEO

John Lubniewski (60 yo)

6.9yrs

Tenure

US$913,891

Compensation

Mr. John L. Lubniewski serves as President of HTG Molecular Diagnostics, Inc. since April 16, 2018 and also serves as its Chief Executive Officer since April 2019. Mr. Lubniewski served as Chief Operating...

Leadership Team

NamePositionTenureCompensationOwnership
John Lubniewski
President6.9yrsUS$913.89kno data
Shaun McMeans
Senior VP13.1yrsUS$580.32kno data
Laura Godlewski
Senior Vice President of Finance & Administration3.2yrsno datano data
Debra Gordon
Senior VP & Chief Legal Counsel13.8yrsUS$296.70kno data
Patrick Roche
Senior Vice President of Research & Development10.9yrsUS$507.38kno data
Stephen Barat
Senior Vice President of Therapeutics3.4yrsno datano data
Christina Carruthers
Vice President of Target Strategy & Early Developmentno datano datano data
Debrah Thompson
Vice President of Scientific Innovationno datano datano data

8.9yrs

Average Tenure

61yo

Average Age

Experienced Management: HTGM.Q's management team is seasoned and experienced (8.9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
John Lubniewski
President5.9yrsUS$913.89kno data
Michelle Griffin
Independent Director6.6yrsUS$54.75kno data
Lee McCracken
Independent Director9.4yrsUS$49.41kno data
Ann Hanham
Independent Chairman of the Board8.6yrsUS$80.05kno data
Thomas Dubensky
Independent Director2.6yrsUS$11.00kno data
Christopher Kiritsy
Non-Employee Independent Director3.2yrsUS$53.83kno data
Davide Ruggero
Member of Scientific Advisory Boardno datano datano data
Frank Slack
Member of Scientific Advisory Boardno datano datano data
Robert Spitale
Member of Therapeutics Scientific Advisory Board3.1yrsno datano data
Amir Horowitz
Member of Scientific Advisory Boardno datano datano data
Mateusz Koptyra
Member of Scientific Advisory Boardno datano datano data
Kendall Van Keuren-Jensen
Member of Scientific Advisory Boardno datano datano data

5.9yrs

Average Tenure

63yo

Average Age

Experienced Board: HTGM.Q's board of directors are considered experienced (5.9 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/13 18:03
End of Day Share Price 2025/03/13 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

HTG Molecular Diagnostics, Inc. is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mark MassaroCanaccord Genuity
Kristen KluskaCantor Fitzgerald & Co.
Alexander NowakCraig-Hallum Capital Group LLC